Study on the efficacy and safety of controlled low central venous pressure assisted thermal ablation of liver tumors

The Application of Controlled Low Central Venous Pressure During Thermal Ablation of Liver Tumors

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200059073

Enrollment

Unknown

Registered

2022-04-23

Start date

2021-12-01

Completion date

Unknown

Last updated

2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ablation of liver cancer

Interventions

Normal state group:Ablation is performed under normal conditions

Low CVP group:Ablation is performed under low CVP conditions

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Liver cancer was confirmed by pathological results or clinically confirmed; 2. The lesions were clearly displayed on two-dimensional ultrasound; 3. The patients were 18-65 years old; 4. The patients had normal blood pressure, no serious liver, kidney, and heart dysfunction, and no contrast agent allergy.

Exclusion criteria

Exclusion criteria: 1. Patients with incomplete necrosis of the lesion after TACE; 2. Patients undergoing combination therapy.

Design outcomes

Primary

Measure	Time frame
Size of ablation necrosis;	—

Secondary

Measure	Time frame
Vital signs;Contrast perfusion peak;	—

Countries

China

Contacts

Public ContactLi Kai

The Third Affiliated Hospital of Sun Yat-Sen University

DAIFEI182@163.com+86 18216054995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026